| Product Code: ETC9960898 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Bipolar Disorder Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Bipolar Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Bipolar Disorder Market - Industry Life Cycle |
3.4 United States (US) Bipolar Disorder Market - Porter's Five Forces |
3.5 United States (US) Bipolar Disorder Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 United States (US) Bipolar Disorder Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
4 United States (US) Bipolar Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about mental health disorders |
4.2.2 Advances in treatment options and therapies |
4.2.3 Growing emphasis on early diagnosis and intervention |
4.3 Market Restraints |
4.3.1 Stigma associated with mental health conditions |
4.3.2 High cost of medications and treatments |
4.3.3 Limited access to mental health services in certain regions |
5 United States (US) Bipolar Disorder Market Trends |
6 United States (US) Bipolar Disorder Market, By Types |
6.1 United States (US) Bipolar Disorder Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Bipolar Disorder Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 United States (US) Bipolar Disorder Market Revenues & Volume, By Mood stabilizer, 2021- 2031F |
6.1.4 United States (US) Bipolar Disorder Market Revenues & Volume, By Anticonvulsants, 2021- 2031F |
6.1.5 United States (US) Bipolar Disorder Market Revenues & Volume, By Antipsychotic drugs, 2021- 2031F |
6.1.6 United States (US) Bipolar Disorder Market Revenues & Volume, By Antidepressant drugs, 2021- 2031F |
6.2 United States (US) Bipolar Disorder Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Bipolar Disorder Market Revenues & Volume, By Selective serotonin reuptake inhibitor, 2021- 2031F |
6.2.3 United States (US) Bipolar Disorder Market Revenues & Volume, By Serotonin norepinephrine reuptake inhibitor, 2021- 2031F |
6.2.4 United States (US) Bipolar Disorder Market Revenues & Volume, By Tricyclic antidepressant drugs, 2021- 2031F |
6.2.5 United States (US) Bipolar Disorder Market Revenues & Volume, By Monoamine oxidase inhibitors, 2021- 2031F |
6.2.6 United States (US) Bipolar Disorder Market Revenues & Volume, By Benzodiazepines, 2021- 2031F |
6.2.7 United States (US) Bipolar Disorder Market Revenues & Volume, By Beta blockers, 2021- 2031F |
7 United States (US) Bipolar Disorder Market Import-Export Trade Statistics |
7.1 United States (US) Bipolar Disorder Market Export to Major Countries |
7.2 United States (US) Bipolar Disorder Market Imports from Major Countries |
8 United States (US) Bipolar Disorder Market Key Performance Indicators |
8.1 Number of new diagnosed cases of bipolar disorder |
8.2 Percentage of patients receiving appropriate treatment |
8.3 Research and development investment in new therapies for bipolar disorder |
9 United States (US) Bipolar Disorder Market - Opportunity Assessment |
9.1 United States (US) Bipolar Disorder Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 United States (US) Bipolar Disorder Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
10 United States (US) Bipolar Disorder Market - Competitive Landscape |
10.1 United States (US) Bipolar Disorder Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Bipolar Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here